In a significant finding, two-dose Ivermectin prophylaxis has led to 73 per cent reduction in COVID-19 infection among healthcare workers (HCWs), who are more likely to contract the virus given their nature of job.
The findings of the study conducted by AIIMS-Bhubaneswar between September 20 and October 19 is set to give a new dimension to the ongoing research on the behaviour of SARS-CoV2 and prevention and treatment of COVID-19.
Ivermectin is one among several potential drugs explored for its therapeutic and preventive role in COVID-19 infection. The study conducted by 12 physicians of AIIMS-BBSR aimed at exploring the association between Ivermectin prophylaxis and development of COVID-19 infection.
Read The New Indian Express article Ivermectin prophylaxis leads to 73 per cent reduction in Covid infection